Antoxis Company
Antoxis is developing treatments for various neurological conditions.
Funding Status:
Seed
Industry:
Reactive Oxygen Species
Estimated Revenue:
Less than $1M
Technology:
Anti-infective Drugs
Headquarters:
Aberdeen, Aberdeen City, United Kingdom
Last Funding Type:
Seed
Employee Number:
1-10
Investors Number:
2
Founded Date:
2005